工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Engineering dense tumor constructs via cellular contraction of extracellular matrix hydrogels.
Engineering dense tumor constructs via cellular contraction of extracellular matrix hydrogels.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
实体瘤的物理特征,如致密的内部微结构和病理性硬度,会影响癌症进展和治疗。虽然通常可以设计弹性模量接近肿瘤的培养基质和支架,但这些模型往往无法捕捉特征性的内部微结构,例如基质界面处致密压实的同心ECM纤维。具有收缩性的间充质细胞可以通过变形、收缩和压实细胞外基质(ECM)水凝胶来降低组织体积并增加组织密度,从而解决这一工程挑战。
在此,我们证明,允许不同来源的人成纤维细胞自由收缩与癌细胞的细胞球共接种的含I型胶原水凝胶,可产生具有模拟体内致密实体瘤结构特征的组织工程构建体。形态学分析和力学测试与增殖和活力的生化分析同步进行,以确认使用该方法构建的致密癌构建体以可操作的格式捕捉了实体癌的相关物理特征,同时保持活力并适合延长培养。所报道的方法可适用于使用多种间充质细胞类型,以及在ECM中加入纤维蛋白并结合接种内皮细胞以产生预血管化构建体。使用该方法构建的物理致密癌构建体可能为研究癌症病理生理学以及大分子药物和细胞免疫疗法向实体瘤递送所面临的挑战提供更具临床相关性的平台。
Physical characteristics of solid tumors such as dense internal microarchitectures and pathological stiffness influence cancer progression and treatment. While it is routine to engineer culture substrates and scaffolds with elastic moduli that approximate tumors, these models often fail to capture characteristic internal microarchitectures such as densely compacted concentric ECM fibers at the stromal interface.
Contractile mesenchymal cells can solve this engineering challenge by deforming, contracting, and compacting extracellular matrix (ECM) hydrogels to decrease tissue volume and increase tissue density.
Here we demonstrate that allowing human fibroblasts of varying origins to freely contract collagen type I-containing hydrogels co-seeded with carcinoma cell spheroids produces a tissue engineered construct with structural features that mimic dense solid tumors in vivo. Morphometry and mechanical testing were conducted in tandem with biochemical analysis of proliferation and viability to confirm that dense carcinoma constructs engineered using this approach capture relevant physical characteristics of solid carcinomas in a tractable format that preserves viability and is amenable to extended culture.
The reported method is adaptable to the use of multiple mesenchymal cell types and the inclusion of fibrin in the ECM combined with seeding of endothelial cells to produce prevascularized constructs. The physical dense carcinoma constructs engineered using this approach may provide more clinically relevant venues for studying cancer pathophysiology and the challenges associated with the delivery of macromolecular drugs and cellular immunotherapies to solid tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。